← Insider buys
SRPT

Sarepta Therapeutics, Inc. · Healthcare

Director Richard Barry bought $453K of Sarepta Therapeutics, Inc.

Bought$453,250
$122.50Price
3,700Shares

What SRPT did for a copier

Prices for SRPT after this filing aren't in yet.

Richard Barry's record

7 other buys with 3 months of prices since 2019: on average +4.2% against the S&P 500, and 3 of 7 beat it.

We're building an app that can copy buys like this into your own brokerage. Join the waitlist

Traded Wed, Aug 14. Filed Wed, Aug 14, 12:38 PM ET, during the session. Not investment advice.